Walgreens Boots Alliance (NASDAQ:WBA) PT Raised to $10.00 at Evercore ISI

Walgreens Boots Alliance (NASDAQ:WBA) had its price target boosted by Evercore ISI from $7.50 to $10.00 in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has an in-line rating on the pharmacy operator’s stock.

A number of other equities analysts also recently weighed in on the stock. Barclays dropped their price target on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a research note on Tuesday, July 23rd. Bank of America reduced their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. JPMorgan Chase & Co. dropped their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, September 12th. Finally, Royal Bank of Canada lowered their price objective on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $13.38.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $10.79 on Wednesday. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance has a 52-week low of $8.22 and a 52-week high of $27.05. The business’s 50 day moving average is $9.41 and its two-hundred day moving average is $13.10. The firm has a market cap of $9.31 billion, a price-to-earnings ratio of -1.60, a PEG ratio of 1.06 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. During the same period in the prior year, the company posted $0.67 EPS. The business’s revenue for the quarter was up 5.9% compared to the same quarter last year. Analysts forecast that Walgreens Boots Alliance will post 2.85 EPS for the current fiscal year.

Hedge Funds Weigh In On Walgreens Boots Alliance

Several institutional investors and hedge funds have recently bought and sold shares of the company. Capital World Investors grew its holdings in shares of Walgreens Boots Alliance by 57.5% during the first quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock worth $630,334,000 after purchasing an additional 10,612,373 shares in the last quarter. Thompson Siegel & Walmsley LLC boosted its stake in Walgreens Boots Alliance by 98.8% during the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after purchasing an additional 2,992,648 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its holdings in shares of Walgreens Boots Alliance by 6.1% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,718,659 shares of the pharmacy operator’s stock valued at $32,882,000 after purchasing an additional 156,484 shares during the last quarter. Newport Trust Company LLC bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter valued at about $31,028,000. Finally, Ariel Investments LLC grew its position in shares of Walgreens Boots Alliance by 10.8% during the 2nd quarter. Ariel Investments LLC now owns 2,038,878 shares of the pharmacy operator’s stock valued at $24,660,000 after acquiring an additional 198,891 shares during the period. 58.59% of the stock is owned by institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.